Sophie Desbiens

Director, New Product Commercialization at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Sophie Desbiens's Colleagues at Alnylam Pharmaceuticals
Brandon Kittredge

Senior Manufacturing Associate

Contact Brandon Kittredge

Sean Rhyee

Director, Global Patient Safety and Risk Management

Contact Sean Rhyee

Neveen Wang

Rare Disease Business Account Executive

Contact Neveen Wang

Maya Chang

Medical Information Manager

Contact Maya Chang

Peter Ray

VP, Strategy & Portfolio Analytics

Contact Peter Ray

Joseph Sheehan

Manager - Engineering Systems

Contact Joseph Sheehan

View All Sophie Desbiens's Colleagues
Sophie Desbiens's Contact Details
HQ
(617) 551-8200
Location
Cambridge, Massachusetts
Company
Alnylam Pharmaceuticals
Sophie Desbiens's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Sophie Desbiens
Sophie Desbiens currently works for Alnylam Pharmaceuticals.
Sophie Desbiens's role at Alnylam Pharmaceuticals is Director, New Product Commercialization.
Sophie Desbiens's email address is ***@alnylam.com. To view Sophie Desbiens's full email address, please signup to ConnectPlex.
Sophie Desbiens works in the SaaS industry.
Sophie Desbiens's colleagues at Alnylam Pharmaceuticals are Brandon Kittredge, Sean Rhyee, Neveen Wang, Maya Chang, Melissa Mobley, Peter Ray, Joseph Sheehan and others.
Sophie Desbiens's phone number is (617) 551-8200
See more information about Sophie Desbiens